company background image
8225

China Health Group SEHK:8225 Stock Report

Last Price

HK$0.29

Market Cap

HK$293.6m

7D

5.4%

1Y

-39.2%

Updated

24 Sep, 2022

Data

Company Financials
8225 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance1/6
Financial Health6/6
Dividends0/6

8225 Stock Overview

China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People’s Republic of China.

China Health Group Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for China Health Group
Historical stock prices
Current Share PriceHK$0.29
52 Week HighHK$0.51
52 Week LowHK$0.26
Beta-2.01
1 Month Change-1.67%
3 Month Change-7.81%
1 Year Change-39.18%
3 Year Change158.77%
5 Year Change99.32%
Change since IPO-28.05%

Recent News & Updates

Shareholder Returns

8225HK Life SciencesHK Market
7D5.4%-10.7%-3.4%
1Y-39.2%-59.9%-25.0%

Return vs Industry: 8225 exceeded the Hong Kong Life Sciences industry which returned -59.9% over the past year.

Return vs Market: 8225 underperformed the Hong Kong Market which returned -25% over the past year.

Price Volatility

Is 8225's price volatile compared to industry and market?
8225 volatility
8225 Average Weekly Movement7.2%
Life Sciences Industry Average Movement7.0%
Market Average Movement6.3%
10% most volatile stocks in HK Market12.7%
10% least volatile stocks in HK Market3.1%

Stable Share Price: 8225 is not significantly more volatile than the rest of Hong Kong stocks over the past 3 months, typically moving +/- 7% a week.

Volatility Over Time: 8225's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199844n/ahttps://www.chgi.net

China Health Group Inc., an investment holding company, provides clinical research services to pharmaceutical and biotechnology companies in the People’s Republic of China. The company offers contracted clinical research services; contracted pharmaceutical development services; post launch market research, medical, and medical market services; medical science liaisons; and other medical services. It also provides hospital management, medical tourism, and specialized hospital services, as well as Venturepharma cloud; and sells drug technologies.

China Health Group Inc. Fundamentals Summary

How do China Health Group's earnings and revenue compare to its market cap?
8225 fundamental statistics
Market CapHK$293.63m
Earnings (TTM)HK$32.36m
Revenue (TTM)HK$72.47m

9.1x

P/E Ratio

4.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
8225 income statement (TTM)
RevenueCN¥65.81m
Cost of RevenueCN¥11.17m
Gross ProfitCN¥54.64m
Other ExpensesCN¥25.25m
EarningsCN¥29.39m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)0.03
Gross Margin83.03%
Net Profit Margin44.66%
Debt/Equity Ratio0.0%

How did 8225 perform over the long term?

See historical performance and comparison